FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Fate Therapeutics
Fate Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
Northwestern University